The FDA Approves Weight Loss Drug Zepbound, a Wegovy and Ozempic Rival
Eli Lilly is about to release Zepbound, a new entrant in the superheated competition for blockbuster weight loss drugs.
Related articles
-
Drones temporarily ground Dubai Airport flights
February 15, 2019 -
Israeli-Palestinian violence rises after Trump peace plan
February 6, 2020 -
Gamergate’s Aggrieved Men Still Haunt the Internet
August 14, 2024
